Evidence map›Paper›PMID 38822910›Full record

ArticleArchives of dermatological research2024

A miRNA-based epigenetic molecular clock for biological skin-age prediction.

Jose Vicente Roig-Genoves, José Luis García-Giménez, Salvador Mena-Molla

Abstract read
In one paragraph

Article in Archives of dermatological research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. A Sex-Specific Minimal CpG-Based Model for Biological Aging UsingInternational journal of molecular sciences · 2025
    Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jose Vicente Roig-GenovesRara Avis Biotec S.L, Parc Científic de la Universitat de Valencia, Paterna, 46980, Spain.
José Luis García-GiménezConsortium Center for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos III, Valencia, 46010, Spain.ORCID https://orcid.org/0000-0001-7547-7872
Salvador Mena-MollaINCLIVA Health Research Institute, INCLIVA, Valencia, 46010, Spain. salvador.mena@uv.es.ORCID https://orcid.org/0000-0002-6423-4741

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skin aging is one of the visible characteristics of the aging process in humans. In recent years, different biological clocks have been generated based on protein or epigenetic markers, but few have focused on biological age in the skin. Arrest the aging process or even being able to restore an organism from an older to a younger stage is one of the main challenges in the last 20 years in biomedical research. We have implemented several machine learning models, including regression and classification algorithms, in order to create an epigenetic molecular clock based on miRNA expression profiles of healthy subjects to predict biological age-related to skin. Our best models are capable of classifying skin samples according to age groups (18-28; 29-39; 40-50; 51-60 or 61-83 years old) with an accuracy of 80% or predict age with a mean absolute error of 10.89 years using the expression levels of 1856 unique miRNAs. Our results suggest that this kind of epigenetic clocks arises as a promising tool with several applications in the pharmaco-cosmetic industry.

Indexed as

Epigenesis, GeneticMachine LearningMicroRNAsSkinSkin AgingAdolescentAdultAgedAged, 80 and overBiological ClocksFemaleGene Expression ProfilingHumansMaleMiddle AgedYoung AdultMicroRNAsAgingElasticNetMachine learningPredictionSkinSuppor Vector classifier

Identifiers

PMID38822910
PMCPMC11144124

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.